BridgeBio Oncology Therapeutics, Inc. (BBOT) stock
BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.80−0.14 (-6.96%)
Close on Nov 18, 2026Market cap $144.72MP/E –Yield –
BridgeBio Oncology Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
BridgeBio Oncology Therapeutics's price to book ratio was 0.6× on Nov 11, 2026, against 2.2× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | −1.6 |
| 2025 | Dec 31, 2025 | 2.2× | – |
See a number that looks wrong?